epidermal growth factor receptor (EGFR) gene mutation
Jump to navigation
Jump to search
Indications
- eligibility for erlotinib in the treatment of non-small cell lung cancer[1]
- useful if KRAS gene mutation is negative
Specimen
- specimen collected from fine needle aspiration
- formalin fixation, parafin embedded
- transport: room temperature or refrigerated
- frozen is unacceptable
Procedure
- polymerase chain reaction with pyrosequencing
- detects mutations in EGFR exons 18, 19, 20, & 21
- if EGFR gene mutation is negative, consider
- if EGFR gene mutation is positive, consider
More general terms
Additional terms
References
- ↑ 1.0 1.1 FDA News Release: May 14, 2013 FDA approves first companion diagnostic to detect gene mutation associated with a type of lung cancer. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm352230.htm
- ↑ ARUP Consult: Lung Cancer deprecated reference